GeneNews is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases.
Latest News: Colon Cancer On Rise In Young Adults
ColonSentry® Can Asses Your Risk and Provide Actionable Clinical Information for Doctors and Patients
ColonSentry® is a blood-based test that can assess a patient's current risk of having colorectal cancer. The test is not considered a replacement for colonoscopy, but rather a more convenient step in determining early warning signs of colon cancer. ColonSentry does not require patients to provide a stool sample, nor does it require any dietary restrictions like fasting or refraining from certain foods or medications prior to taking the test. The ColonSentry test is easy to perform and blood can be drawn at the same time as other tests.
Our ColonSentry Test Is Now Available throughout U.S.
In The News
Promising Early Results of 10,000 Patient Lung Cancer Screening Trial Using EarlyCDT(R)-Lung
The Times (Sep 4, 2015) - A blood test for lung cancer on the NHS is a step closer after “exciting” early results from a trial of 10,000 Scottish smokers.The study invites people who are over 50 and have smoked the equivalent of a pack of cigarettes a day for 20 years to have regular testing.Initial results, to be presented on Monday at the International Association for the Study of Lung Cancer’s 16th world conference, suggest that the EarlyCDT-Lung cancer blood test picks up eight out of ten lung cancers.Read More